Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Anemia

  Free Subscription


Articles published in Br J Haematol

Retrieve available abstracts of 258 articles:
HTML format



Single Articles


    June 2021
  1. PATON C, Mathews L, Groarke EM, Rios O, et al
    COVID-19 infection in patients with severe aplastic anaemia.
    Br J Haematol. 2021;193:902-905.
    PubMed    


  2. HANDS K, Taylor C, Kotze A, Richards T, et al
    Preoperative patient blood management during the SARS-CoV-2 pandemic.
    Br J Haematol. 2021;193:1087-1092.
    PubMed    


    April 2021
  3. CALABRETTA E, Moraleda JM, Iacobelli M, Jara R, et al
    COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies.
    Br J Haematol. 2021;193:43-51.
    PubMed    


    February 2021
  4. CAIRO MS, Savani BN
    Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived.
    Br J Haematol. 2021;192:678-680.
    PubMed    


  5. OLSON TS
    Paediatric severe aplastic anaemia treatment: where to start?
    Br J Haematol. 2021;192:417-419.
    PubMed    


  6. ALZAHRANI M, Damlaj M, Jeffries N, Alahmari B, et al
    Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.
    Br J Haematol. 2021;192:761-768.
    PubMed     Abstract available


  7. YUAN S, Jordan LC, Davis LT, Cogswell PM, et al
    A cross-sectional, case-control study of intracranial arterial wall thickness and complete blood count measures in sickle cell disease.
    Br J Haematol. 2021;192:769-777.
    PubMed     Abstract available


  8. GROARKE EM, Patel BA, Gutierrez-Rodrigues F, Rios O, et al
    Eltrombopag added to immunosuppression for children with treatment-naive severe aplastic anaemia.
    Br J Haematol. 2021;192:605-614.
    PubMed     Abstract available


  9. HOTINSKI AK, Best OG, Thurgood LA, Lower KM, et al
    A biclonal case of chronic lymphocytic leukaemia with discordant mutational status of the immunoglobulin heavy chain variable region and bimodal CD49d expression.
    Br J Haematol. 2021;192:e77-e81.
    PubMed    


  10. DEMBELE AK, Lapoumeroulie C, Diaw M, Tessougue O, et al
    Cell-derived microparticles and sickle cell disease chronic vasculopathy in sub-Saharan Africa: A multinational study.
    Br J Haematol. 2021;192:634-642.
    PubMed     Abstract available


  11. VITRANO A, Meloni A, Addario Pollina W, Karimi M, et al
    A complication risk score to evaluate clinical severity of thalassaemia syndromes.
    Br J Haematol. 2021;192:626-633.
    PubMed     Abstract available


  12. CASTLEMAN JS, Moise KJ Jr, Kilby MD
    Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation.
    Br J Haematol. 2021;192:425-432.
    PubMed     Abstract available


    January 2021
  13. KULASEKARARAJ AG, Marsh JCW
    Romiplostim in aplastic anaemia - another tool in the armamentarium.
    Br J Haematol. 2021;192:15-16.
    PubMed    


  14. MINGOIA M, Caria CA, Ye L, Asunis I, et al
    Induction of therapeutic levels of HbF in genome-edited primary beta(0) 39-thalassaemia haematopoietic stem and progenitor cells.
    Br J Haematol. 2021;192:395-404.
    PubMed     Abstract available



  15. Developing the evidence base for the management of autoimmune haemolytic anaemia (AIHA): the UK experience.
    Br J Haematol. 2021;192:e54-e57.
    PubMed    


  16. SHARMA POUDYAL B, Gyawali B, Rondelli D
    The need for locally generated data in haematology: a real-world experience of aplastic anaemia in Nepal.
    Br J Haematol. 2021;192:e63-e65.
    PubMed    


  17. GREGOIRE-PELCHAT P, Pastore Y, Robitaille N, LeMay S, et al
    Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial.
    Br J Haematol. 2021;192:385-394.
    PubMed     Abstract available


  18. PATEL A, Gan K, Li AA, Weiss J, et al
    Machine-learning algorithms for predicting hospital re-admissions in sickle cell disease.
    Br J Haematol. 2021;192:158-170.
    PubMed     Abstract available


  19. JANG JH, Tomiyama Y, Miyazaki K, Nagafuji K, et al
    Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
    Br J Haematol. 2021;192:190-199.
    PubMed     Abstract available


  20. CHAN LKL, Mak VWM, Chan SCH, Yu ELM, et al
    Liver complications of haemoglobin H disease in adults.
    Br J Haematol. 2021;192:171-178.
    PubMed     Abstract available


  21. MTENGA J, Orf K, Zheng J, Chamba C, et al
    Haematopoietic stem cell transplantation in Tanzania.
    Br J Haematol. 2021;192:17-21.
    PubMed    


  22. SPEICH C, Wegmuller R, Brittenham GM, Zeder C, et al
    Measurement of long-term iron absorption and loss during iron supplementation using a stable isotope of iron ((57) Fe).
    Br J Haematol. 2021;192:179-189.
    PubMed     Abstract available


  23. MANARA R, Dalla Torre A, Lucchetta M, Ermani M, et al
    Visual cortex changes in children with sickle cell disease and normal visual acuity: a multimodal magnetic resonance imaging study.
    Br J Haematol. 2021;192:151-157.
    PubMed     Abstract available


    December 2020
  24. RUND D
    The evolution of clinical research in thalassaemia: where has all the funding gone?
    Br J Haematol. 2020;191:666-667.
    PubMed    


  25. JOBANPUTRA M, Paramore C, Laird SG, McGahan M, et al
    Co-morbidities and mortality associated with transfusion-dependent beta-thalassaemia in patients in England: a 10-year retrospective cohort analysis.
    Br J Haematol. 2020;191:897-905.
    PubMed     Abstract available


  26. URIO F, Nkya S, Rooks H, Mgaya JA, et al
    F cell numbers are associated with an X-linked genetic polymorphism and correlate with haematological parameters in patients with sickle cell disease.
    Br J Haematol. 2020;191:888-896.
    PubMed     Abstract available


  27. FORTE S, Eng B, Verhovsek M, Soulieres D, et al
    Microcytosis in patients with haemoglobin C trait: is alpha-thalassaemia trait to blame?
    Br J Haematol. 2020;191:e129-e131.
    PubMed    


  28. TANG D, Liu S, Sun H, Qin X, et al
    All-trans-retinoic acid shifts Th1 towards Th2 cell differentiation by targeting NFAT1 signalling to ameliorate immune-mediated aplastic anaemia.
    Br J Haematol. 2020;191:906-919.
    PubMed     Abstract available


  29. PECKER LH, Hussain S, Christianson MS, Lanzkron S, et al
    Hydroxycarbamide exposure and ovarian reserve in women with sickle cell disease in the Multicenter Study of Hydroxycarbamide.
    Br J Haematol. 2020;191:880-887.
    PubMed     Abstract available


  30. VALI S, Mukhtar S, Nandi A, Wilson K, et al
    Cumulative outcome of pre-implantation genetic diagnosis for sickle cell disease: a 5-year review.
    Br J Haematol. 2020;191:875-879.
    PubMed     Abstract available


    November 2020
  31. VERLHAC S, Gabor F, Paillard C, Chateil JF, et al
    Improved stenosis outcome in stroke-free sickle cell anemia children after transplantation compared to chronic transfusion.
    Br J Haematol. 2020 Nov 20. doi: 10.1111/bjh.17178.
    PubMed     Abstract available


  32. WEI Z, Yang G, Huang Y, Peng P, et al
    A 15-years follow-up of deferasirox in beta-thalassaemia major patients with iron overload.
    Br J Haematol. 2020;191:e81-e83.
    PubMed    


  33. PEZINA-CANTU C, Gomez-De Leon A, Jaime-Perez JC, Colunga-Pedraza P, et al
    Pernicious anaemia can be treated effectively with a single high dose of cobalamin.
    Br J Haematol. 2020;191:e97-e100.
    PubMed    


  34. SIRIWORADETKUN S, Thubthed R, Thiengtavor C, Paiboonsukwong K, et al
    Elevated levels of circulating monocytic myeloid derived suppressor cells in splenectomised beta-thalassaemia/HbE patients.
    Br J Haematol. 2020;191:e72-e76.
    PubMed    


  35. HAN J, Holden CC, Ahluwalia AY, Molokie RE, et al
    Chronic opioid use can be reduced or discontinued after haematopoietic stem cell transplantation for sickle cell disease.
    Br J Haematol. 2020;191:e70-e72.
    PubMed    


  36. PEFFAULT DE LATOUR R, Brodsky RA, Ortiz S, Risitano AM, et al
    Pharmacokinetic and pharmacodynamic effects of ravulizumab and eculizumab on complement component 5 in adults with paroxysmal nocturnal haemoglobinuria: results of two phase 3 randomised, multicentre studies.
    Br J Haematol. 2020;191:476-485.
    PubMed     Abstract available


  37. TOLE S, Dhir P, Pugi J, Drury LJ, et al
    Genotype-phenotype correlation in children with hereditary spherocytosis.
    Br J Haematol. 2020;191:486-496.
    PubMed     Abstract available


    October 2020
  38. HERISHANU Y, Levi S, Kamdjou T, Bornstein Y, et al
    Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.
    Br J Haematol. 2020 Oct 23. doi: 10.1111/bjh.17105.
    PubMed    


  39. SHEHA D, El-Shayeb M, Eid Y, Amin M, et al
    Unfolding of sickle cell trait by coronavirus disease 2019 (COVID-19) infection.
    Br J Haematol. 2020;191:e38-e40.
    PubMed    


  40. PIKE A, Muus P, Munir T, Mitchell L, et al
    COVID-19 infection in patients on anti-complement therapy: The Leeds National Paroxysmal Nocturnal Haemoglobinuria service experience.
    Br J Haematol. 2020;191:e1-e4.
    PubMed    


  41. ROIZENBLATT S, Cabanas-Pedro AC, Figueiredo MS
    Rheumatoid arthritis and sickle cell disease: A potential association.
    Br J Haematol. 2020;191:e25-e28.
    PubMed    


  42. BARGEHR C, Crazzolara R
    Cabot rings and other peripheral blood features of Imerslund-Grasbeck syndrome.
    Br J Haematol. 2020;191:11.
    PubMed    


  43. TEOFILI L, Papacci P, Orlando N, Bianchi M, et al
    Allogeneic cord blood transfusions prevent fetal haemoglobin depletion in preterm neonates. Results of the CB-TrIP study.
    Br J Haematol. 2020;191:263-268.
    PubMed     Abstract available


  44. RICCHI P, Meloni A, Pistoia L, Spasiano A, et al
    Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study.
    Br J Haematol. 2020;191:107-114.
    PubMed     Abstract available


    September 2020
  45. NESR G, Koshy R, Foldes D, Kagdi H, et al
    Autoimmune haemolytic anaemia and a marked rise in the lymphocyte count associated with COVID-19 in a patient with treatment-naive chronic lymphocytic leukaemia: a case report.
    Br J Haematol. 2020;190:e326-e328.
    PubMed    


  46. OLATUNYA OS
    Poverty and severity of childhood sickle cell disease.
    Br J Haematol. 2020;190:819-821.
    PubMed    


  47. WOUTERS HJCM, Stam SP, van der Klauw MM, Bakker SJL, et al
    The association between haemoglobin concentrations and muscle mass determined from urinary creatinine excretion rate: a population-based cohort study.
    Br J Haematol. 2020;190:e349-e352.
    PubMed    


  48. GERARD D, Bourin S, Phulpin A, Picard V, et al
    Previously misdiagnosed red cell membrane disorder and familial consequences.
    Br J Haematol. 2020;190:810.
    PubMed    


  49. LIAPIS K, Vrachiolias G, Spanoudakis E, Kotsianidis I, et al
    Vacuolation of early erythroblasts with ring sideroblasts: a clue to the diagnosis of linezolid toxicity.
    Br J Haematol. 2020;190:809.
    PubMed    


  50. MCGINNIS E, Smith TW
    Clostridium perfringens sepsis with spherocytosis and green neutrophil inclusions.
    Br J Haematol. 2020;190:641.
    PubMed    


  51. DE SANTIS GC, Costa TCM, Santos FLS, da Silva-Pinto AC, et al
    Blood transfusion support for sickle cell patients during haematopoietic stem cell transplantation: a single-institution experience.
    Br J Haematol. 2020;190:e295-e297.
    PubMed    


  52. BELLO-MANGA H, Galadanci AA, Abdullahi S, Ali S, et al
    Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.
    Br J Haematol. 2020;190:939-944.
    PubMed     Abstract available


    August 2020
  53. KULASEKARARAJ AG, Lazana I, Large J, Posadas K, et al
    Terminal complement inhibition dampens the inflammation during COVID-19.
    Br J Haematol. 2020;190:e141-e143.
    PubMed    


  54. KARIMI M, Haghpanah S, Azarkeivan A, Zahedi Z, et al
    Prevalence and mortality in beta-thalassaemias due to outbreak of novel coronavirus disease (COVID-19): the nationwide Iranian experience.
    Br J Haematol. 2020;190:e137-e140.
    PubMed    


  55. APPIAH-KUBI A, Acharya S, Fein Levy C, Vlachos A, et al
    Varying presentations and favourable outcomes of COVID-19 infection in children and young adults with sickle cell disease: an additional case series with comparisons to published cases.
    Br J Haematol. 2020;190:e221-e224.
    PubMed    


  56. KULASEKARARAJ AG
    Regulatory cells in immune-mediated aplastic anaemia - not Tregs but Bregs.
    Br J Haematol. 2020;190:486-487.
    PubMed    


  57. GIBSON JS
    A novel mechanism for pathogenesis of sickle cell disease with therapeutic implications: Band 3 tyrosine phosphorylation.
    Br J Haematol. 2020;190:488-489.
    PubMed    


  58. COLOMBATTI R, Andemariam B
    Microvasculopathy and biomarkers in sickle cell disease: the promise of non-invasive real-time in vivo tools.
    Br J Haematol. 2020;190:309-310.
    PubMed    


  59. MALINOWSKI AK
    Thrombotic microangiopathy in pregnancy: when you hear hoofbeats, consider the zebras?
    Br J Haematol. 2020;190:306-308.
    PubMed    


  60. MOURA PL, Dobbe JGG, Streekstra GJ, Rab MAE, et al
    Rapid diagnosis of hereditary haemolytic anaemias using automated rheoscopy and supervised machine learning.
    Br J Haematol. 2020;190:e250-e255.
    PubMed    


  61. ANDREWS C, Maze D, Murphy T, Sibai H, et al
    Combination treatment with CPX-351 and midostaurin in patients with secondary acute myeloid leukaemia that are FLT3 mutated: three cases and review of literature.
    Br J Haematol. 2020;190:467-470.
    PubMed    


  62. FILIPPIDOU M, Avgerinou G, Tsipou H, Tourkantoni N, et al
    Longitudinal evaluation of eltrombopag in paediatric acquired severe aplastic anaemia.
    Br J Haematol. 2020;190:e157-e159.
    PubMed    


  63. FUNG EB, Ahmad T, Killilea DW, Hussain R, et al
    Zinc supplementation improves markers of glucose homeostasis in thalassaemia.
    Br J Haematol. 2020;190:e162-e166.
    PubMed    


  64. LUEWAN S, Charoenkwan P, Sirichotiyakul S, Tongsong T, et al
    Fetal haemoglobin H-Constant Spring disease: a role for intrauterine management.
    Br J Haematol. 2020;190:e233-e236.
    PubMed    


  65. NOOMUNA P, Risinger M, Zhou S, Seu K, et al
    Inhibition of Band 3 tyrosine phosphorylation: a new mechanism for treatment of sickle cell disease.
    Br J Haematol. 2020;190:599-609.
    PubMed     Abstract available


  66. TIMMERMANS SAMEG, Werion A, Spaanderman MEA, Reutelingsperger CP, et al
    The natural course of pregnancies in women with primary atypical haemolytic uraemic syndrome and asymptomatic relatives.
    Br J Haematol. 2020;190:442-449.
    PubMed     Abstract available


  67. ZAIMOKU Y, Patel BA, Kajigaya S, Feng X, et al
    Deficit of circulating CD19(+) CD24(hi) CD38(hi) regulatory B cells in severe aplastic anaemia.
    Br J Haematol. 2020;190:610-617.
    PubMed     Abstract available


  68. SAMARRON SL, Miller JW, Cheung AT, Chen PC, et al
    Homocysteine is associated with severity of microvasculopathy in sickle cell disease patients.
    Br J Haematol. 2020;190:450-457.
    PubMed     Abstract available


  69. WILSON S, Ellsworth P, Key NS
    Pregnancy in sickle cell trait: what we do and don't know.
    Br J Haematol. 2020;190:328-335.
    PubMed     Abstract available


    July 2020
  70. HEILBRONNER C, Berteloot L, Tremolieres P, Dupic L, et al
    Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.
    Br J Haematol. 2020;190:e21-e24.
    PubMed    


  71. SAHU KK, Siddiqui AD, Cerny J
    Managing sickle cell patients with COVID-19 infection: the need to pool our collective experience.
    Br J Haematol. 2020;190:e86-e89.
    PubMed    


  72. LI M, Nguyen CB, Yeung Z, Sanchez K, et al
    Evans syndrome in a patient with COVID-19.
    Br J Haematol. 2020;190:e59-e61.
    PubMed    


  73. MCCLOSKEY KA, Meenan J, Hall R, Tsitsikas DA, et al
    COVID-19 infection and sickle cell disease: a UK centre experience.
    Br J Haematol. 2020;190:e57-e58.
    PubMed    


  74. CHAKRAVORTY S, Rees D
    Commentary on sickle cell non-invasive prenatal testing article.
    Br J Haematol. 2020;190:20-21.
    PubMed    


  75. JEREBTSOVA M, Taye A, Smith N, Afangbedji N, et al
    Association between plasma and urinary orosomucoid and chronic kidney disease in adults with sickle cell disease.
    Br J Haematol. 2020;190:e45-e48.
    PubMed    


  76. PEDROSA AM, Lemes RPG
    Gene expression of HIF-1alpha and VEGF in response to hypoxia in sickle cell anaemia: Influence of hydroxycarbamide.
    Br J Haematol. 2020;190:e39-e42.
    PubMed     Abstract available


  77. NARDO-MARINO A, Brousse V, Rees D
    Emerging therapies in sickle cell disease.
    Br J Haematol. 2020;190:149-172.
    PubMed     Abstract available


  78. KATTAMIS A
    Diamond-Blackfan anaemia: understanding an old disease.
    Br J Haematol. 2020;190:14-15.
    PubMed    


  79. VAN CAMPEN J, Silcock L, Yau S, Daniel Y, et al
    A novel non-invasive prenatal sickle cell disease test for all at-risk pregnancies.
    Br J Haematol. 2020;190:119-124.
    PubMed     Abstract available


  80. QUARELLO P, Garelli E, Carando A, Cillario R, et al
    A 20-year long term experience of the Italian Diamond-Blackfan Anaemia Registry: RPS and RPL genes, different faces of the same disease?
    Br J Haematol. 2020;190:93-104.
    PubMed     Abstract available


    June 2020
  81. HUSSAIN FA, Njoku FU, Saraf SL, Molokie RE, et al
    COVID-19 infection in patients with sickle cell disease.
    Br J Haematol. 2020;189:851-852.
    PubMed    


  82. LUZZATTO L
    PNH phenotypes and their genesis.
    Br J Haematol. 2020;189:802-805.
    PubMed    


  83. HYACINTH HI, Idris IM
    Cognitive deficit in sickle cell disease: Is hydroxyurea part of the story?
    Br J Haematol. 2020;189:1014-1015.
    PubMed    


  84. GIRELLI D, Busti F
    ERFE regulation in sickle cell disease: complex but promising.
    Br J Haematol. 2020;189:1012-1013.
    PubMed    


  85. KHAMPHIKHAM P, Nualkaew T, Pongpaksupasin P, Kaewsakulthong W, et al
    High-level induction of fetal haemoglobin by pomalidomide in beta-thalassaemia/HbE erythroid progenitor cells.
    Br J Haematol. 2020;189:e240-e245.
    PubMed    


  86. BREWIN JN, Crowley MP, Kesse-Adu R, Stuart-Smith S, et al
    Catheter associated thromboses in patients with sickle cell anaemia and dual lumen Vortex apheresis ports are common and can be clinically asymptomatic.
    Br J Haematol. 2020;189:e198-e200.
    PubMed    


  87. PARTANEN M, Kang G, Wang WC, Krull K, et al
    Association between hydroxycarbamide exposure and neurocognitive function in adolescents with sickle cell disease.
    Br J Haematol. 2020;189:1192-1203.
    PubMed     Abstract available


  88. RICHARDS SJ, Dickinson AJ, Cullen MJ, Griffin M, et al
    Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
    Br J Haematol. 2020;189:954-966.
    PubMed     Abstract available


  89. PRATS-MARTIN C, Mezquita L, Garcia-Canale S, Jimenez-Jambrina M, et al
    Numerous abnormal mitoses in parvovirus B19-infected proerythroblasts.
    Br J Haematol. 2020;189:800.
    PubMed    


  90. MANGAONKAR AA, Thawer F, Son J, Ajebo G, et al
    Regulation of iron homeostasis through the erythroferrone-hepcidin axis in sickle cell disease.
    Br J Haematol. 2020;189:1204-1209.
    PubMed     Abstract available


  91. AL-ALI HK, Griesshammer M, Foltz L, Palumbo GA, et al
    Primary analysis of JUMP, a phase 3b, expanded-access study evaluating the safety and efficacy of ruxolitinib in patients with myelofibrosis, including those with low platelet counts.
    Br J Haematol. 2020;189:888-903.
    PubMed     Abstract available


  92. PATEL BJ, Barot SV, Kuzmanovic T, Kerr C, et al
    Distinctive and common features of moderate aplastic anaemia.
    Br J Haematol. 2020;189:967-975.
    PubMed     Abstract available


    May 2020
  93. ZAGORSKI E, Pawar T, Rahimian S, Forman D, et al
    Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19).
    Br J Haematol. 2020 May 27. doi: 10.1111/bjh.16892.
    PubMed     Abstract available


  94. ANGILERI F, Legare S, Marino Gammazza A, Conway de Macario E, et al
    Is molecular mimicry the culprit in the autoimmune hemolytic anemia affecting COVID-19 patients?
    Br J Haematol. 2020 May 26. doi: 10.1111/bjh.16883.
    PubMed     Abstract available


  95. LAZARIAN G, Quinquenel A, Bellal M, Siavellis J, et al
    Autoimmune hemolytic anemia associated with Covid-19 infection.
    Br J Haematol. 2020 May 6. doi: 10.1111/bjh.16794.
    PubMed     Abstract available


  96. LOPEZ C, Kim J, Pandey A, Huang T, et al
    Simultaneous Onset of COVID-19 and Autoimmune Hemolytic Anemia.
    Br J Haematol. 2020 May 5. doi: 10.1111/bjh.16786.
    PubMed     Abstract available


  97. ROY NBA, Telfer P, Eleftheriou P, de la Fuente J, et al
    Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID-19 pandemic.
    Br J Haematol. 2020;189:635-639.
    PubMed     Abstract available


  98. ANTELO G, Mangaonkar AA, Coltro G, Buradkar A, et al
    Response to erythropoiesis-stimulating agents in patients with WHO-defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T).
    Br J Haematol. 2020;189:e104-e108.
    PubMed    


  99. SHAH BN, Hassan TO, Zhang X, McClain DA, et al
    Increased iron stores influence glucose metabolism in sickle cell anaemia.
    Br J Haematol. 2020;189:e184-e187.
    PubMed    


  100. SKINNER S, Ling Liu K, Lo M, Josset-Lamaugarny A, et al
    Alterations in vascular reactivity in a transgenic mouse model of sickle cell trait.
    Br J Haematol. 2020;189:e154-e157.
    PubMed    


  101. GOUVEIA C, Duarte M, Norte S, Alves P, et al
    Osteoarticular infections in paediatric sickle cell disease: in the era of multidrugresistant bacteria.
    Br J Haematol. 2020;189:e147-e150.
    PubMed    


  102. PHILIP KEJ, Sadaka AS, Polkey MI, Hopkinson NS, et al
    The prevalence and associated mortality of non-anaemic iron deficiency in older adults: a 14 years observational cohort study.
    Br J Haematol. 2020;189:566-572.
    PubMed     Abstract available


  103. LEONARD A, Tisdale J, Abraham A
    Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
    Br J Haematol. 2020;189:408-423.
    PubMed     Abstract available


  104. MCCORMICK M, Richardson T, Warady BA, Novelli EM, et al
    Acute kidney injury in paediatric patients with sickle cell disease is associated with increased morbidity and resource utilization.
    Br J Haematol. 2020;189:559-565.
    PubMed     Abstract available


    April 2020
  105. ALI JS, Andrasik F, Berlin KS, Porter J, et al
    Attention difficulties are associated with lower engagement in adult care amongst youth with sickle cell disease.
    Br J Haematol. 2020;189:e27-e30.
    PubMed    


  106. FAYAND A, Dzierzynski N, Georgin-Lavialle S, Bachmeyer C, et al
    The association of psychiatric comorbidities with emergency visits and hospitalisations in adult sickle-cell patients: a cohort study.
    Br J Haematol. 2020;189:e21-e23.
    PubMed    


  107. ROPER D, Layton M, Rees D, Lambert C, et al
    Laboratory diagnosis of G6PD deficiency. A British Society for Haematology Guideline.
    Br J Haematol. 2020;189:24-38.
    PubMed    


  108. THIENGTAVOR C, Siriworadetkun S, Paiboonsukwong K, Fucharoen S, et al
    Increased ferritin levels in non-transfusion-dependent beta degrees -thalassaemia/HbE are associated with reduced CXCR2 expression and neutrophil migration.
    Br J Haematol. 2020;189:187-198.
    PubMed     Abstract available


  109. FUJISAWA M, Yasumoto A, Kato H, Sugawara Y, et al
    The role of anti-complement factor H antibodies in the development of atypical haemolytic uremic syndrome: a possible contribution to abnormality of platelet function.
    Br J Haematol. 2020;189:182-186.
    PubMed     Abstract available


  110. NICKEL RS, Horan JT, Abraham A, Qayed M, et al
    Human leukocyte antigen (HLA) class I antibodies and transfusion support in paediatric HLA-matched haematopoietic cell transplant for sickle cell disease.
    Br J Haematol. 2020;189:162-170.
    PubMed     Abstract available


  111. QUARTA A, Sgherza N, Pasanisi A, Solfrizzi MP, et al
    Switching from dispersible to film coated tablet formulation of deferasirox improves hemoglobin levels and transfusional interval in patients with transfusion-dependent-thalassemia.
    Br J Haematol. 2020;189:e60-e63.
    PubMed    


    March 2020
  112. AUERBACH M, Georgieff MK
    Guidelines for iron deficiency in pregnancy: hope abounds: Commentary to accompany: UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:814-816.
    PubMed    


  113. AGGARWAL A, Jamwal M, Sharma P, Sachdeva MUS, et al
    Deciphering molecular heterogeneity of Indian families with hereditary spherocytosis using targeted next-generation sequencing: First South Asian study.
    Br J Haematol. 2020;188:784-795.
    PubMed     Abstract available


  114. HANSEN S, Wood DK, Higgins JM
    5-(Hydroxymethyl)furfural restores low-oxygen rheology of sickle trait blood in vitro.
    Br J Haematol. 2020;188:985-993.
    PubMed     Abstract available


  115. CORNELISSE AC, Bergkamp FJM, Griffioen-Keijzer A
    Haemolytic anaemia: an unrecognised side effect of hydroxyurea?
    Br J Haematol. 2020;188:e80-e81.
    PubMed    


  116. STALLINGS AM, Majhail NS, Nowacki AS, Onimoe GI, et al
    Paediatric haematologists' attitudes regarding haematopoietic cell transplantation as treatment for sickle cell disease.
    Br J Haematol. 2020;188:976-984.
    PubMed     Abstract available


  117. PAVORD S, Daru J, Prasannan N, Robinson S, et al
    UK guidelines on the management of iron deficiency in pregnancy.
    Br J Haematol. 2020;188:819-830.
    PubMed    


    February 2020
  118. NZE C, Fortin B, Freedman R, Mandell E, et al
    Sudden death in sickle cell disease: current experience.
    Br J Haematol. 2020;188:e43-e45.
    PubMed    


  119. SANCHEZ-PETITTO G, Drachenberg CB, Mannuel HD, Law JY, et al
    An unusual presentation of paroxysmal nocturnal haemoglobinuria.
    Br J Haematol. 2020;188:347.
    PubMed    


  120. SHAH S, Sheth R, Shah K, Patel K, et al
    Safety and effectiveness of thalidomide and hydroxyurea combination in beta-thalassaemia intermedia and major: a retrospective pilot study.
    Br J Haematol. 2020;188:e18-e21.
    PubMed    


  121. PEREIRA-MARTINS DA, Coelho-Silva JL, Domingos IF, Weinhauser I, et al
    Association between ANXA2*5681 polymorphism (rs7170178) and osteonecrosis in haemoglobin SS-genotyped patients.
    Br J Haematol. 2020;188:e8-e11.
    PubMed    


  122. DUTTA D, Aujla A, Knoll BM, Lim SH, et al
    Intestinal pathophysiological and microbial changes in sickle cell disease: Potential targets for therapeutic intervention.
    Br J Haematol. 2020;188:488-493.
    PubMed     Abstract available


  123. SAITO-BENZ M, Flanagan P, Berry MJ
    Management of anaemia in pre-term infants.
    Br J Haematol. 2020;188:354-366.
    PubMed     Abstract available


    January 2020
  124. SCHOLS S, Nunn MA, Mackie I, Weston-Davies W, et al
    Successful treatment of a PNH patient non-responsive to eculizumab with the novel complement C5 inhibitor coversin (nomacopan).
    Br J Haematol. 2020;188:334-337.
    PubMed    


  125. WANG Y, McReynolds LJ, Dagnall C, Katki HA, et al
    Pre-transplant short telomeres are associated with high mortality risk after unrelated donor haematopoietic cell transplant for severe aplastic anaemia.
    Br J Haematol. 2020;188:309-316.
    PubMed     Abstract available


    April 2019
  126. SCHOLZ GA, Leichtle AB, Scherer A, Arndt U, et al
    The links of hepcidin and erythropoietin in the interplay of inflammation and iron deficiency in a large observational study of rheumatoid arthritis.
    Br J Haematol. 2019 Apr 2. doi: 10.1111/bjh.15895.
    PubMed     Abstract available


  127. RUND D
    Bittersweet news for the adult sickle cell patient.
    Br J Haematol. 2019;185:9-10.
    PubMed    


  128. ZHOU J, Han J, Nutescu EA, Galanter WL, et al
    Similar burden of type 2 diabetes among adult patients with sickle cell disease relative to African Americans in the U.S. population: a six-year population-based cohort analysis.
    Br J Haematol. 2019;185:116-127.
    PubMed     Abstract available


  129. NASHASHIBI J, Avraham GR, Schwartz N, Awni Y, et al
    Intravenous iron treatment reduces coagulability in patients with iron deficiency anaemia: a longitudinal study.
    Br J Haematol. 2019;185:93-101.
    PubMed     Abstract available


  130. BELISARIO AR, Vieira ELM, de Almeida JA, Mendes FG, et al
    Low urinary levels of angiotensin-converting enzyme 2 may contribute to albuminuria in children with sickle cell anaemia.
    Br J Haematol. 2019;185:190-193.
    PubMed    


  131. MORISSENS M, Castro Rodriguez J, Azerad MA, Besse-Hammer T, et al
    Added value of speckle tracking in the evaluation of cardiac function in patients with sickle cell disease.
    Br J Haematol. 2019;185:151-153.
    PubMed    


  132. BRUNSON A, Keegan THM, Mahajan A, Paulukonis S, et al
    Cancer specific survival in patients with sickle cell disease.
    Br J Haematol. 2019;185:128-132.
    PubMed     Abstract available


  133. DAY ME, Rodeghier M, Driggers J, Bean CJ, et al
    A significant proportion of children of African descent with HbSbeta(0) thalassaemia are inaccurately diagnosed based on phenotypic analyses alone.
    Br J Haematol. 2019;185:153-156.
    PubMed    


    March 2019
  134. GRACE RF, Mark Layton D, Barcellini W
    How we manage patients with pyruvate kinase deficiency.
    Br J Haematol. 2019;184:721-734.
    PubMed     Abstract available


  135. WHITE J, Lindgren M, Liu K, Gao X, et al
    Sevuparin blocks sickle blood cell adhesion and sickle-leucocyte rolling on immobilized L-selectin in a dose dependent manner.
    Br J Haematol. 2019;184:873-876.
    PubMed    


  136. PELLEGRIN S, Haydn-Smith KL, Hampton-O'Neil LA, Hawley BR, et al
    Transduction with BBF2H7/CREB3L2 upregulates SEC23A protein in erythroblasts and partially corrects the hypo-glycosylation phenotype associated with CDAII.
    Br J Haematol. 2019;184:876-881.
    PubMed    


  137. ALTER BP, Giri N
    Serum alpha fetoprotein levels in Fanconi anaemia.
    Br J Haematol. 2019;184:1074-1076.
    PubMed    


  138. BERGER G, van den Berg E, Smetsers S, Leegte BK, et al
    Fanconi anaemia presenting as acute myeloid leukaemia and myelodysplastic syndrome in adulthood: a family report on co-occurring FANCC and CHEK2 mutations.
    Br J Haematol. 2019;184:1071-1073.
    PubMed    


  139. JIANG H, Zhang H, Wang Y, Qi W, et al
    Sirolimus for the treatment of multi-resistant pure red cell aplasia.
    Br J Haematol. 2019;184:1055-1058.
    PubMed    


  140. SALEM B, Mitchell R, DeFor TE, Tryon R, et al
    Elevations in serum alpha fetoprotein levels in patients with Fanconi anaemia.
    Br J Haematol. 2019;184:1032-1035.
    PubMed    


  141. KANTER J, Heath LE, Knorr J, Agbenyega ET, et al
    Novel findings from the multinational DOVE study on geographic and age-related differences in pain perception and analgesic usage in children with sickle cell anaemia.
    Br J Haematol. 2019;184:1058-1061.
    PubMed    


    February 2019
  142. MCGOWAN KE, Malinowski AK, Schuh AC, Whittle W, et al
    Aplastic anaemia in pregnancy - a single centre, North American series.
    Br J Haematol. 2019;184:436-439.
    PubMed     Abstract available


  143. LUZZATTO L, Notaro R
    The "escape" model: a versatile mechanism for clonal expansion.
    Br J Haematol. 2019;184:465-466.
    PubMed    


  144. RAVERA S, Degan P, Sabatini F, Columbaro M, et al
    Altered lipid metabolism could drive the bone marrow failure in fanconi anaemia.
    Br J Haematol. 2019;184:693-696.
    PubMed    


  145. DARBARI DS, Liljencrantz J, Ikechi A, Martin S, et al
    Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant.
    Br J Haematol. 2019;184:690-693.
    PubMed    


  146. MARKUS C, Saxon B, Metz M
    Ferritin as a functional biomarker of iron status in children and young adults.
    Br J Haematol. 2019;184:640-642.
    PubMed    


  147. MALINOWSKI AK, Cheung P, Yang J, D'Souza R, et al
    Cord gas parameters in infants born to women with sickle cell disease: a retrospective matched cohort study.
    Br J Haematol. 2019;184:653-657.
    PubMed    


  148. MAJUMDAR S, Tirona R, Mashegu H, Desai J, et al
    A phase 1 dose-finding study of intravenous L-citrulline in sickle cell disease: a potential novel therapy for sickle cell pain crisis.
    Br J Haematol. 2019;184:634-636.
    PubMed    


    January 2019
  149. BARTELS M, Bierings M
    How I manage children with Diamond-Blackfan anaemia.
    Br J Haematol. 2019;184:123-133.
    PubMed     Abstract available


  150. ALEXANDRE-HEYMANN L, Dubert M, Diallo DA, Diop S, et al
    Prevalence and correlates of growth failure in young African patients with sickle cell disease.
    Br J Haematol. 2019;184:253-262.
    PubMed     Abstract available


  151. THROWER A, Ciccone EJ, Maitra P, Derebail VK, et al
    Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease.
    Br J Haematol. 2019;184:246-252.
    PubMed     Abstract available


  152. KANTER J, Abboud MR, Kaya B, Nduba V, et al
    Ticagrelor does not impact patient-reported pain in young adults with sickle cell disease: a multicentre, randomised phase IIb study.
    Br J Haematol. 2019;184:269-278.
    PubMed     Abstract available


  153. SHAH A, Wray K, James T, Shine B, et al
    Serum hepcidin potentially identifies iron deficiency in survivors of critical illness at the time of hospital discharge.
    Br J Haematol. 2019;184:279-281.
    PubMed    


    December 2018
  154. NAKAYAMA S, Taniguchi T, Tanaka H, Espinoza JL, et al
    Interleukin-17-producing angioimmunoblastic T-cell lymphoma with Evans syndrome.
    Br J Haematol. 2018 Dec 28. doi: 10.1111/bjh.15733.
    PubMed    


  155. PARK S, Greenberg P, Yucel A, Farmer C, et al
    Clinical effectiveness and safety of erythropoietin-stimulating agents for the treatment of low- and intermediate-1-risk myelodysplastic syndrome: a systematic literature review.
    Br J Haematol. 2018 Dec 13. doi: 10.1111/bjh.15707.
    PubMed     Abstract available


    November 2018
  156. YANAMANDRA U, Senee H, Yanamadra S, Das SK, et al
    Erythropoietin and ferritin response in native highlanders aged 4-19 years from the Leh-Ladakh region of India.
    Br J Haematol. 2018 Nov 26. doi: 10.1111/bjh.15553.
    PubMed     Abstract available


    June 2018
  157. HAN J, Zhang X, Saraf SL, Gowhari M, et al
    Risk factors for vitamin D deficiency in sickle cell disease.
    Br J Haematol. 2018;181:828-835.
    PubMed     Abstract available


  158. GUEDENEY P, Lionnet F, Ceccaldi A, Stankovic Stojanovic K, et al
    Cardiac manifestations in sickle cell disease varies with patient genotype.
    Br J Haematol. 2018;181:664-671.
    PubMed     Abstract available


  159. KARAFIN MS, Westlake M, Hauser RG, Tormey CA, et al
    Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.
    Br J Haematol. 2018;181:672-681.
    PubMed     Abstract available


    May 2018
  160. QURESHI A, Kaya B, Pancham S, Keenan R, et al
    Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline.
    Br J Haematol. 2018;181:460-475.
    PubMed    


  161. SAULTIER P, Loosveld M, Benoist JF, Michel G, et al
    Pancytopenia and megaloblastic erythropoiesis reveal a novel GIF mutation.
    Br J Haematol. 2018;181:304.
    PubMed    


  162. BERENTSEN S
    How I manage patients with cold agglutinin disease.
    Br J Haematol. 2018;181:320-330.
    PubMed     Abstract available


  163. JONASSAINT CR, Birenboim A, Jorgensen DR, Novelli EM, et al
    The association of smartphone-based activity space measures with cognitive functioning and pain sickle cell disease.
    Br J Haematol. 2018;181:395-397.
    PubMed    


  164. DAGUR PK, McCoy JP, Nichols J, Mendelsohn L, et al
    Haem augments and iron chelation decreases toll-like receptor 4 mediated inflammation in monocytes from sickle cell patients.
    Br J Haematol. 2018;181:552-554.
    PubMed    


    April 2018
  165. ZAHR RS, Chappa P, Yin H, Brown LA, et al
    Renal protection by atorvastatin in a murine model of sickle cell nephropathy.
    Br J Haematol. 2018;181:111-121.
    PubMed     Abstract available


  166. RANKINE-MULLINGS AE, Morrison-Levy N, Soares D, Aldred K, et al
    Transcranial Doppler velocity among Jamaican children with sickle cell anaemia: determining the significance of haematological values and nutrition.
    Br J Haematol. 2018;181:242-251.
    PubMed     Abstract available


  167. SOUSOS N, Sinakos E, Klonizakis P, Adamidou D, et al
    Deferasirox improves liver fibrosis in beta-thalassaemia major patients. A five-year longitudinal study from a single thalassaemia centre.
    Br J Haematol. 2018;181:140-142.
    PubMed    


    March 2018
  168. VOGEL S, Thein SL
    Platelets at the crossroads of thrombosis, inflammation and haemolysis.
    Br J Haematol. 2018;180:761-767.
    PubMed     Abstract available


  169. RICCHI P, Meloni A, Spasiano A, Costantini S, et al
    The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients.
    Br J Haematol. 2018;180:721-726.
    PubMed     Abstract available


  170. JIANG Z, Luo HY, Farrell JJ, Zhang Z, et al
    A variant Sp1 (R218Q) transcription factor might enhance HbF expression in beta(0) -thalassaemia homozygotes.
    Br J Haematol. 2018;180:755-757.
    PubMed    


  171. PEPE A, Gamberini MR, Missere M, Pistoia L, et al
    Gender differences in the development of cardiac complications: a multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow-up.
    Br J Haematol. 2018;180:879-888.
    PubMed     Abstract available


  172. KERAGALA CB, Draxler DF, McQuilten ZK, Medcalf RL, et al
    Haemostasis and innate immunity - a complementary relationship: A review of the intricate relationship between coagulation and complement pathways.
    Br J Haematol. 2018;180:782-798.
    PubMed     Abstract available


    February 2018
  173. TJON JM, de Groot MR, Sypkens Smit SMA, de Wreede LC, et al
    Short-term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemia.
    Br J Haematol. 2018;180:459-462.
    PubMed    


  174. REES DC, Robinson S, Howard J
    How I manage red cell transfusions in patients with sickle cell disease.
    Br J Haematol. 2018;180:607-617.
    PubMed     Abstract available


  175. WILLEN SM, Rodeghier M, Strunk RC, Bacharier LB, et al
    Aeroallergen sensitization predicts acute chest syndrome in children with sickle cell anaemia.
    Br J Haematol. 2018;180:571-577.
    PubMed     Abstract available


  176. EKONG A, Berg L, Amos RJ, Tsitsikas DA, et al
    Regular automated red cell exchange transfusion in the management of stuttering priapism complicating sickle cell disease.
    Br J Haematol. 2018;180:585-588.
    PubMed    


  177. VACLAVU L, Baldew ZAV, Gevers S, Mutsaerts HJMM, et al
    Intracranial 4D flow magnetic resonance imaging reveals altered haemodynamics in sickle cell disease.
    Br J Haematol. 2018;180:432-442.
    PubMed     Abstract available


    January 2018
  178. SAMARASINGHE S, Veys P, Vora A, Wynn R, et al
    Paediatric amendment to adult BSH Guidelines for aplastic anaemia.
    Br J Haematol. 2018;180:201-205.
    PubMed    


  179. WONKAM A, Mnika K, Ngo Bitoungui VJ, Chetcha Chemegni B, et al
    Clinical and genetic factors are associated with pain and hospitalisation rates in sickle cell anaemia in Cameroon.
    Br J Haematol. 2018;180:134-146.
    PubMed     Abstract available


  180. PAIKARI A, Sheehan VA
    Fetal haemoglobin induction in sickle cell disease.
    Br J Haematol. 2018;180:189-200.
    PubMed     Abstract available


  181. CREASEY T, Biss T, Lambert J, Smith F, et al
    Pyridoxine-sensitive X-linked 'sideroblastic' anaemia in the absence of ring sideroblasts - molecular diagnosis.
    Br J Haematol. 2018;180:10.
    PubMed    


  182. BIERINGS M, Bonfim C, Peffault De Latour R, Aljurf M, et al
    Transplant results in adults with Fanconi anaemia.
    Br J Haematol. 2018;180:100-109.
    PubMed     Abstract available


  183. CLARK B, Shooter C, Smith F, Brawand D, et al
    Beta thalassaemia intermedia due to co-inheritance of three unique alpha globin cluster duplications characterised by next generation sequencing analysis.
    Br J Haematol. 2018;180:160-164.
    PubMed    


    December 2017
  184. ROVO A, Kulasekararaj A, Medinger M, Chevallier P, et al
    Association of aplastic anaemia and lymphoma: a report from the severe aplastic anaemia working party of the European Society of Blood and Bone Marrow Transplantation.
    Br J Haematol. 2017 Dec 19. doi: 10.1111/bjh.15074.
    PubMed    


  185. NAIR M, Churchill D, Robinson S, Nelson-Piercy C, et al
    Association between maternal haemoglobin and stillbirth: a cohort study among a multi-ethnic population in England.
    Br J Haematol. 2017;179:829-837.
    PubMed     Abstract available


  186. HAYMANN JP, Hammoudi N, Stankovic Stojanovic K, Galacteros F, et al
    Renin-angiotensin system blockade promotes a cardio-renal protection in albuminuric homozygous sickle cell patients.
    Br J Haematol. 2017;179:820-828.
    PubMed     Abstract available


    November 2017
  187. FRAME IJ, Coberly J, Fuda FS, Chen M, et al
    Erythrophagocytosis by T-cell lymphoma cells in a patient with hereditary spherocytosis post-splenectomy.
    Br J Haematol. 2017 Nov 16. doi: 10.1111/bjh.15028.
    PubMed    


  188. BREWIN J, Kaya B, Chakravorty S
    How I manage sickle cell patients with high transcranial doppler results.
    Br J Haematol. 2017;179:377-388.
    PubMed     Abstract available


  189. ZAPPIA KJ, Guo Y, Retherford D, Wandersee NJ, et al
    Characterization of a mouse model of sickle cell trait: parallels to human trait and a novel finding of cutaneous sensitization.
    Br J Haematol. 2017;179:657-666.
    PubMed     Abstract available


  190. WINCHENNE A, Cecchini J, Deux JF, De Prost N, et al
    A clinical risk score for pulmonary artery thrombosis during acute chest syndrome in adult patients with sickle cell disease.
    Br J Haematol. 2017;179:627-634.
    PubMed     Abstract available


  191. SACHDEV V, Sidenko S, Wu MD, Minniti CP, et al
    Skeletal and myocardial microvascular blood flow in hydroxycarbamide-treated patients with sickle cell disease.
    Br J Haematol. 2017;179:648-656.
    PubMed     Abstract available


  192. MICHELOZZI IM, Pievani A, Pagni F, Antolini L, et al
    Human aplastic anaemia-derived mesenchymal stromal cells form functional haematopoietic stem cell niche in vivo.
    Br J Haematol. 2017;179:669-673.
    PubMed    


    October 2017
  193. CABANAS-PEDRO AC, Roizenblatt S, de Souza AAL, Tufik S, et al
    Periodic limb movement in sleep and sickle cell disease: a neglected association?
    Br J Haematol. 2017;179:154-157.
    PubMed     Abstract available


  194. VASSEUR C, Domingues-Hamdi E, Ledudal K, Le Corvoisier P, et al
    Red blood cells free alpha-haemoglobin pool: a biomarker to monitor the beta-thalassemia intermedia variability. The ALPHAPOOL study.
    Br J Haematol. 2017;179:142-153.
    PubMed     Abstract available


  195. AL BALUSHI HWM, Wali Y, Al Awadi M, Al-Subhi T, et al
    The super sickling haemoglobin HbS-Oman: a study of red cell sickling, K+ permeability and associations with disease severity in patients heterozygous for HbA and HbS-Oman (HbA/S-Oman genotype).
    Br J Haematol. 2017;179:256-265.
    PubMed     Abstract available


  196. KORMANN R, Jannot AS, Narjoz C, Ribeil JA, et al
    Roles of APOL1 G1 and G2 variants in sickle cell disease patients: kidney is the main target.
    Br J Haematol. 2017;179:323-335.
    PubMed     Abstract available


    September 2017
  197. DI MAGGIO R, Maggio A
    The new era of chelation treatments: effectiveness and safety of 10 different regimens for controlling iron overloading in thalassaemia major.
    Br J Haematol. 2017;178:676-688.
    PubMed     Abstract available


  198. NARITA A, Muramatsu H, Okuno Y, Sekiya Y, et al
    Development of clinical paroxysmal nocturnal haemoglobinuria in children with aplastic anaemia.
    Br J Haematol. 2017;178:954-958.
    PubMed     Abstract available


  199. PUNARO E, Feltrin KY, Reis F
    Magnetic resonance imaging in acaeruloplasminaemia - a rare differential diagnosis of microcytic anaemia with iron overload.
    Br J Haematol. 2017;178:837.
    PubMed    


    August 2017
  200. PARK HS, Park SN, Im K, Kim SM, et al
    Telomere length and somatic mutations in correlation with response to immunosuppressive treatment in aplastic anaemia.
    Br J Haematol. 2017;178:603-615.
    PubMed     Abstract available


  201. GEARD A, Pule GD, Chetcha Chemegni B, Ngo Bitoungui VJ, et al
    Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.
    Br J Haematol. 2017;178:629-639.
    PubMed     Abstract available


  202. MOCKESCH B, Connes P, Charlot K, Skinner S, et al
    Association between oxidative stress and vascular reactivity in children with sickle cell anaemia and sickle haemoglobin C disease.
    Br J Haematol. 2017;178:468-475.
    PubMed     Abstract available


  203. BROWN FC, Collett M, Tremblay CS, Rank G, et al
    Loss of Dynamin 2 GTPase function results in microcytic anaemia.
    Br J Haematol. 2017;178:616-628.
    PubMed     Abstract available


  204. LANCELOT M, White J, Sarnaik S, Hines P, et al
    Low molecular weight heparin inhibits sickle erythrocyte adhesion to VCAM-1 through VLA-4 blockade in a standardized microfluidic flow adhesion assay.
    Br J Haematol. 2017;178:479-481.
    PubMed    


  205. ROSE C, Callebaut I, Pascal L, Oudin C, et al
    Lethal ALAS2 mutation in males X-linked sideroblastic anaemia.
    Br J Haematol. 2017;178:648-651.
    PubMed    


  206. FISHER AE, Oduro AKY, Adzaku F, Telfer P, et al
    Presentations of sickle cell disease patients to hospital in Ghana: key findings from a preliminary study at Volta Regional Hospital.
    Br J Haematol. 2017;178:489-491.
    PubMed    


    July 2017
  207. DUFOUR C
    How I manage patients with Fanconi anaemia.
    Br J Haematol. 2017;178:32-47.
    PubMed     Abstract available


  208. BRUNSON A, Lei A, Rosenberg AS, White RH, et al
    Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.
    Br J Haematol. 2017;178:319-326.
    PubMed     Abstract available


  209. CHELI E, Roze J, Garrot T, Tagarist S, et al
    Usefulness of the EMA flow cytometric test in the diagnosis of hereditary spherocytosis post-transfusion.
    Br J Haematol. 2017;178:180.
    PubMed    


    June 2017
  210. DUCASSOU S, Leverger G, Fernandes H, Chambost H, et al
    Benefits of rituximab as a second-line treatment for autoimmune haemolytic anaemia in children: a prospective French cohort study.
    Br J Haematol. 2017;177:751-758.
    PubMed     Abstract available


  211. COATES TD, Wood JC
    How we manage iron overload in sickle cell patients.
    Br J Haematol. 2017;177:703-716.
    PubMed     Abstract available


  212. MAKUBI A, Roberts DJ
    Investigation and treatment for iron deficiency in heart failure: the unmet need in Lower and Middle Income Countries.
    Br J Haematol. 2017;177:896-904.
    PubMed     Abstract available


  213. TUBMAN VN, Makani J
    Turf wars: exploring splenomegaly in sickle cell disease in malaria-endemic regions.
    Br J Haematol. 2017;177:938-946.
    PubMed     Abstract available


  214. JONKER FAM, Te Poel E, Bates I, Boele van Hensbroek M, et al
    Anaemia, iron deficiency and susceptibility to infection in children in sub-Saharan Africa, guideline dilemmas.
    Br J Haematol. 2017;177:878-883.
    PubMed     Abstract available


  215. TLUWAY F, Makani J
    Sickle cell disease in Africa: an overview of the integrated approach to health, research, education and advocacy in Tanzania, 2004-2016.
    Br J Haematol. 2017;177:919-929.
    PubMed     Abstract available


  216. MWANGI MN, Prentice AM, Verhoef H
    Safety and benefits of antenatal oral iron supplementation in low-income countries: a review.
    Br J Haematol. 2017;177:884-895.
    PubMed     Abstract available


  217. MAKUBI A, Mmbando BP, Novelli EM, Lwakatare J, et al
    Rates and risk factors of hypertension in adolescents and adults with sickle cell anaemia in Tanzania: 10 years' experience.
    Br J Haematol. 2017;177:930-937.
    PubMed     Abstract available


  218. MACKAREL J, Iatan M, Kumar L, Storey L, et al
    In support of upfront stem cell transplantation as first-line therapy for paediatric patients with idiopathic severe aplastic anaemia who lack a sibling donor.
    Br J Haematol. 2017;177:806-808.
    PubMed    


    May 2017
  219. KILLICK SB, Bown N, Cavenagh J, Dokal I, et al
    British Committee for Standards in Haematology guidelines for aplastic anemia: Single centre retrospective review finds no compelling evidence for the recommended higher platelet count threshold of 20 x 109 /L - RESPONSE to Yan et al.
    Br J Haematol. 2017 May 23. doi: 10.1111/bjh.14766.
    PubMed    


  220. ALLALI S, Peyrard T, Amiranoff D, Cohen JF, et al
    Prevalence and risk factors for red blood cell alloimmunization in 175 children with sickle cell disease in a French university hospital reference centre.
    Br J Haematol. 2017;177:641-647.
    PubMed     Abstract available


  221. CYBULSKA A, Meintker L, Ringwald J, Krause SW, et al
    Measurements of immature platelets with haematology analysers are of limited value to separate immune thrombocytopenia from bone marrow failure.
    Br J Haematol. 2017;177:612-619.
    PubMed     Abstract available


  222. HOPPE C, Jacob E, Styles L, Kuypers F, et al
    Simvastatin reduces vaso-occlusive pain in sickle cell anaemia: a pilot efficacy trial.
    Br J Haematol. 2017;177:620-629.
    PubMed     Abstract available


  223. WEGMAN-OSTROSKY T, Savage SA
    The genomics of inherited bone marrow failure: from mechanism to the clinic.
    Br J Haematol. 2017;177:526-542.
    PubMed     Abstract available


  224. STANLEY N, Olson TS, Babushok DV
    Recent advances in understanding clonal haematopoiesis in aplastic anaemia.
    Br J Haematol. 2017;177:509-525.
    PubMed     Abstract available


  225. MEUNIER B, Loosveld M, Grados A, Rico A, et al
    Bone marrow erythrophagocytosis and reticulocytopenia in autoimmune haemolytic anaemia.
    Br J Haematol. 2017;177:346.
    PubMed    


  226. CHARLOT K, Hierso R, Lemonne N, Romana M, et al
    Changes in autonomic nervous activity during vaso-occlusive crisis in patients with sickle cell anaemia.
    Br J Haematol. 2017;177:484-486.
    PubMed    


    April 2017
  227. SINAKOS E, Kountouras D, Koskinas J, Zachou K, et al
    Treatment of chronic hepatitis C with direct-acting antivirals in patients with beta-thalassaemia major and advanced liver disease.
    Br J Haematol. 2017 Apr 25. doi: 10.1111/bjh.14640.
    PubMed     Abstract available


  228. HOSOKAWA K, Kajigaya S, Keyvanfar K, Qiao W, et al
    Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes.
    Br J Haematol. 2017;177:136-141.
    PubMed     Abstract available


  229. BHATIA P, Singh A, Hegde A, Jain R, et al
    Systematic evaluation of paediatric cohort with iron refractory iron deficiency anaemia (IRIDA) phenotype reveals multiple TMPRSS6 gene variations.
    Br J Haematol. 2017;177:311-318.
    PubMed     Abstract available


  230. KULASEKARARAJ AG
    Clonal dominance of PNH- another piece to the jigsaw.
    Br J Haematol. 2017;177:9-10.
    PubMed    


  231. PIPPARD MJ
    Microcytic anaemias in childhood and iron-refractory iron deficiency anaemia.
    Br J Haematol. 2017;177:167-168.
    PubMed    


  232. HILL QA, Stamps R, Massey E, Grainger JD, et al
    Guidelines on the management of drug-induced immune and secondary autoimmune, haemolytic anaemia.
    Br J Haematol. 2017;177:208-220.
    PubMed    


  233. KAWADLER JM, Clark CA, McKinstry RC, Kirkham FJ, et al
    Brain atrophy in paediatric sickle cell anaemia: findings from the silent infarct transfusion (SIT) trial.
    Br J Haematol. 2017;177:151-153.
    PubMed    


    March 2017
  234. PUREV E, Tian X, Aue G, Pantin J, et al
    Allogeneic transplantation using CD34+ selected peripheral blood progenitor cells combined with non-mobilized donor T cells for refractory severe aplastic anaemia.
    Br J Haematol. 2017;176:950-960.
    PubMed     Abstract available


  235. LU J, Lee JH, Huang SY, Qiu L, et al
    Continuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial.
    Br J Haematol. 2017;176:743-749.
    PubMed     Abstract available


  236. HIERSO R, Lemonne N, Villaescusa R, Lalanne-Mistrih ML, et al
    Exacerbation of oxidative stress during sickle vaso-occlusive crisis is associated with decreased anti-band 3 autoantibodies rate and increased red blood cell-derived microparticle level: a prospective study.
    Br J Haematol. 2017;176:805-813.
    PubMed     Abstract available


  237. TAHER AT
    Clinical utility of serum ferritin thresholds for guiding iron chelation therapy when magnetic resonance imaging is unavailable in patients with non-transfusion-dependent thalassaemias - response to Ang et al.
    Br J Haematol. 2017;176:989-990.
    PubMed    


  238. GILL H, Leung GM, Lopes D, Kwong YL, et al
    The thrombopoietin mimetics eltrombopag and romiplostim in the treatment of refractory aplastic anaemia.
    Br J Haematol. 2017;176:991-994.
    PubMed    


  239. WU MY, He Y, Yan JM, Li DZ, et al
    A novel selective deletion of the major alpha-globin regulatory element (MCS-R2) causing alpha-thalassaemia.
    Br J Haematol. 2017;176:984-986.
    PubMed    


    February 2017
  240. DRASAR E, Fitzpatrick E, Gardner K, Awogbade M, et al
    Interim assessment of liver damage in patients with sickle cell disease using new non-invasive techniques.
    Br J Haematol. 2017;176:643-650.
    PubMed     Abstract available


  241. PECKER LH, Schaefer BA, Luchtman-Jones L
    Knowledge insufficient: the management of haemoglobin SC disease.
    Br J Haematol. 2017;176:515-526.
    PubMed     Abstract available


  242. MANARA R, Talenti G, Rampazzo P, Ermani M, et al
    Longitudinal evaluation of cerebral white matter hyperintensities lesion volume in children with sickle cell disease.
    Br J Haematol. 2017;176:485-487.
    PubMed    


  243. HILL QA, Stamps R, Massey E, Grainger JD, et al
    The diagnosis and management of primary autoimmune haemolytic anaemia.
    Br J Haematol. 2017;176:395-411.
    PubMed    


  244. BABUSHOK DV, Stanley N, Xie HM, Huang H, et al
    Clonal Replacement Underlies Spontaneous Remission in Paroxysmal Nocturnal Haemoglobinuria.
    Br J Haematol. 2017;176:487-490.
    PubMed    


    January 2017
  245. VITRANO A, Calvaruso G, Lai E, Colletta G, et al
    The era of comparable life expectancy between thalassaemia major and intermedia: Is it time to revisit the major-intermedia dichotomy?
    Br J Haematol. 2017;176:124-130.
    PubMed     Abstract available


  246. PORTER JB, Cappellini MD, Kattamis A, Viprakasit V, et al
    Iron overload across the spectrum of non-transfusion-dependent thalassaemias: role of erythropoiesis, splenectomy and transfusions.
    Br J Haematol. 2017;176:288-299.
    PubMed     Abstract available


  247. KOSINSKI PD, Croal PL, Leung J, Williams S, et al
    The severity of anaemia depletes cerebrovascular dilatory reserve in children with sickle cell disease: a quantitative magnetic resonance imaging study.
    Br J Haematol. 2017;176:280-287.
    PubMed     Abstract available


  248. DOWLING MM, Quinn CT, Ramaciotti C, Kanter J, et al
    Increased prevalence of potential right-to-left shunting in children with sickle cell anaemia and stroke.
    Br J Haematol. 2017;176:300-308.
    PubMed     Abstract available


  249. GUIDOTTI F, Piatti G, Marcon A, Cassinerio E, et al
    Pulmonary dysfunction in thalassaemia major: is there any relationship with body iron stores?
    Br J Haematol. 2017;176:309-314.
    PubMed     Abstract available


  250. DOWLING MM, Kirkham FJ
    Stroke in sickle cell anaemia is more than stenosis and thrombosis: the role of anaemia and hyperemia in ischaemia.
    Br J Haematol. 2017;176:151-153.
    PubMed    


  251. DAVIS BA, Allard S, Qureshi A, Porter JB, et al
    Guidelines on red cell transfusion in sickle cell disease. Part I: principles and laboratory aspects.
    Br J Haematol. 2017;176:179-191.
    PubMed    


  252. DAVIS BA, Allard S, Qureshi A, Porter JB, et al
    Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion.
    Br J Haematol. 2017;176:192-209.
    PubMed    


  253. LA GIOIA A, Bombara M, Fiorini F, Fiorini M, et al
    Pseudo-Chediak-Higashi granules and other unusual cytoplasmic inclusions in refractory anaemia with excess blasts-2.
    Br J Haematol. 2017;176:156.
    PubMed    


    June 2016
  254. COUQUE N, Girard D, Ducrocq R, Boizeau P, et al
    Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: impact of national guidelines.
    Br J Haematol. 2016;173:927-37.
    PubMed     Abstract available


  255. THOMAS MR, Robinson S, Scully MA
    How we manage thrombotic microangiopathies in pregnancy.
    Br J Haematol. 2016;173:821-30.
    PubMed     Abstract available


  256. KORDE N, Zhang Y, Loeliger K, Poon A, et al
    Monoclonal gammopathy-associated pure red cell aplasia.
    Br J Haematol. 2016;173:876-83.
    PubMed     Abstract available


    May 2016
  257. ASNANI M, Serjeant G, Royal-Thomas T, Reid M, et al
    Predictors of renal function progression in adults with homozygous sickle cell disease.
    Br J Haematol. 2016;173:461-8.
    PubMed     Abstract available


  258. LEONARDO FC, Brugnerotto AF, Domingos IF, Fertrin KY, et al
    Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci.
    Br J Haematol. 2016;173:456-60.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: